LEVOMILNACIPRAN HYDROCHLORIDE |
210790 |
002 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 40MG BASE |
No
|
No
|
2019/02/04
|
2019/02/04
|
AMNEAL PHARMS CO |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210790 |
003 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
No
|
No
|
2019/02/04
|
2019/02/04
|
AMNEAL PHARMS CO |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210790 |
004 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 120MG BASE |
No
|
No
|
2019/02/04
|
2019/02/04
|
AMNEAL PHARMS CO |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210732 |
001 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 20MG BASE |
No
|
No
|
2020/11/05
|
2020/11/05
|
HIKMA |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210732 |
002 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 40MG BASE |
No
|
No
|
2020/11/05
|
2020/11/05
|
HIKMA |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210732 |
003 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
No
|
No
|
2020/11/05
|
2020/11/05
|
HIKMA |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210732 |
004 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 120MG BASE |
No
|
No
|
2020/11/05
|
2020/11/05
|
HIKMA |
Discontinued |
MILNACIPRAN HYDROCHLORIDE |
205367 |
001 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
12.5MG |
No
|
No
|
2020/12/28
(TA)
|
--
|
MYLAN PHARMS INC |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
205367 |
002 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
25MG |
No
|
No
|
2020/12/28
(TA)
|
--
|
MYLAN PHARMS INC |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
205367 |
003 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
50MG |
No
|
No
|
2020/12/28
(TA)
|
--
|
MYLAN PHARMS INC |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
205367 |
004 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
100MG |
No
|
No
|
2020/12/28
(TA)
|
--
|
MYLAN PHARMS INC |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
210944 |
001 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
12.5MG |
No
|
No
|
2022/01/05
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
210944 |
002 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
25MG |
No
|
No
|
2022/01/05
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
210944 |
003 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
50MG |
No
|
No
|
2022/01/05
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
MILNACIPRAN HYDROCHLORIDE |
210944 |
004 |
ANDA |
MILNACIPRAN HYDROCHLORIDE |
TABLET;ORAL |
100MG |
No
|
No
|
2022/01/05
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
LEVOMILNACIPRAN HYDROCHLORIDE |
210826 |
001 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 20MG BASE |
No
|
No
|
2023/01/06
|
2023/01/06
|
AUROBINDO PHARMA LTD |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210826 |
002 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 40MG BASE |
No
|
No
|
2023/01/06
|
2023/01/06
|
AUROBINDO PHARMA LTD |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210826 |
003 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 80MG BASE |
No
|
No
|
2023/01/06
|
2023/01/06
|
AUROBINDO PHARMA LTD |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210826 |
004 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 120MG BASE |
No
|
No
|
2023/01/06
|
2023/01/06
|
AUROBINDO PHARMA LTD |
Discontinued |
LEVOMILNACIPRAN HYDROCHLORIDE |
210771 |
001 |
ANDA |
LEVOMILNACIPRAN HYDROCHLORIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 20MG BASE |
No
|
No
|
2023/03/20
|
2023/03/20
|
PRINSTON INC |
Prescription |